BC Week In Review | Apr 27, 2018
Clinical News

Regenerative Patch Technologies' CPCB-RPE1 successfully implanted in AMD patients

Top-line data from the Phase I portion of a Phase I/IIa trial showed that CPCB-RPE1 from Regenerative Patch Technologies Inc. (Glendale, Calif.) was successfully implanted into an eye of four of five patients with non-neovascular...
Items per page:
1 - 1 of 1